← FDA DRUG APPROVALS

FDA ANDA · ANDA077069

AMIODARONE HYDROCHLORIDE

Sponsor: CHARTWELL RX

APPLICATION
ANDA077069
TYPE
ANDA
ORIGINAL APPROVAL
2005-04-08
LATEST ACTION
2020-07-15
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

AMIODARONE HYDROCHLORIDEPrescription
AMIODARONE HYDROCHLORIDE 400MG · TABLET · ORAL
AMIODARONE HYDROCHLORIDEPrescription
AMIODARONE HYDROCHLORIDE 100MG · TABLET · ORAL
AMIODARONE HYDROCHLORIDEPrescription
AMIODARONE HYDROCHLORIDE 200MG · TABLET · ORAL

Approval history

2020-07-15Labeling · Supplement 11 · standardAP
2020-07-15Labeling · Supplement 12 · standardAP
2020-07-15Labeling · Supplement 10 · standardAP
2015-05-19Labeling · Supplement 7 · standardAP
2015-05-19Labeling · Supplement 5 · standardAP
2015-05-19Labeling · Supplement 8 · standardAP
2013-05-31Labeling · Supplement 4 · standardAP
2007-04-11Labeling · Supplement 2AP
2005-04-08OriginalOther Important Information from FDAAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →